SCHEMBL20037062

SCHEMBL20037062

CCOC(=O)CCc1c(C)[nH]c2ccccc12

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.59
HTT P42858 2/20 0.59
TSHR P16473 1/20 0.59
KDM4E B2RXH2 4/20 0.57
POLB P06746 1/20 0.57
PABPC1 P11940 1/20 0.56
ALOX15 P16050 1/20 0.56
MAPT P10636 4/20 0.56
GAA P10253 1/20 0.56
CASP1 P29466 1/20 0.56
CASP7 P55210 1/20 0.56
KLK6 Q92876 1/20 0.55
EGFR P00533 1/20 0.54
SRC P12931 1/20 0.54
HTR6 P50406 3/20 0.53
CYP3A4 P08684 2/20 0.53
CYP1A2 P05177 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7127236 0.87 EGFR (0.71) ALDH1A1HTTTSHRKDM4EPOLB
SCHEMBL9011379 0.86 HTR6 (0.54) ALDH1A1KDM4EMAPTGAAEGFR
SCHEMBL1165573 0.85 KDM4E (0.68) ALDH1A1HTTTSHRKDM4EPOLB
SCHEMBL31487317 0.85 KDM4E (0.68) ALDH1A1HTTTSHRKDM4EPOLB
SCHEMBL2204353 0.85 HTR6 (0.74) ALDH1A1TSHRKDM4EMAPTGAA
SCHEMBL6701627 0.85 KDM4E (0.68) ALDH1A1KDM4EHTR6HSD17B10HTR1A
SCHEMBL4557305 0.82 ALDH1A1 (0.66) ALDH1A1HTTTSHRKDM4EPOLB
SCHEMBL30343681 0.82 ALDH1A1 (0.71) ALDH1A1HTTTSHRKDM4EPOLB
SCHEMBL5207930 0.82 EGFR (0.66) ALDH1A1HTTTSHRKDM4EPOLB
SCHEMBL1740428 0.82 ALDH1A1 (0.71) ALDH1A1HTTTSHRKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3305781-A1 CHEMICAL SUBSTANCES WHICH INHIBIT THE ENZYMATIC ACTIVITY OF HUMAN KALLIKREIN-RELATED PEPTIDASE 6 (KLK6) Deutsches Krebsforschungszentrum (DE) 2018-04-11 EP disclosed